Websites, domains, hosts that links to novartisoncology.com

Discover more about acute and chronic ITP, as well as its symptoms and treatments. Understand how an ITP diagnosis can have an impact on your daily life.

Iατρικά άρθρα, Ιατρικά δελτία τύπου, Φαρμακευτική ενημέρωση, Ιατρικά Συνέδρια, Ιατρικές Αγγελίες, Νέα Φαρμακευτικά και καλλυντικά προϊόντα, Ιατρικά βιβλία, Ιατρική και νέες τεχνολογίες

The Executive Office of the Association resides in The Hague, The Netherlands, and serves a membership of over 4000 from 100 countries. Over the years, EHA has broadened its activities in order to serve European hematologists in a state-of-the-art execution of their profession.

Novartis Oncology is a global healthcare company that is passionate about the discovery and development of innovative cancer medicines and the advancement or creation of new standards of care.

The AML Global portal aims to expedite learning and disseminate worldwide, the most up-to-date information on AML, amongst academic researchers and treating clinicians, to improve their understanding of the latest advances in terms of basic research and treatment options.

Find information and resources for living with carcinoid syndrome, cancers, and tumors, including nutritional guides, symptom information, and more.

GLIVEC® (imatinib) is indicated for the treatment of unresectable and/or metastatic and adjuvant KIT+ GIST.

KYMRIAH™ is a treatment option for pediatric patients with relapsed or refractory B-cell acute lymphoblastic leukemia. See full Prescribing & Safety Info, including Boxed Warning.

AgahJobs is designed to match executives with new career opportunities and help businesses in Iran find qualified professional managerial staff (i.e. Network Administrator, IT Manager, Marketing Manager, Sales Manager, Purchasing Manager, Finance Manager, Accountant, Executive Secretary, and other middle and senior management positions

Find helpful and accurate information about Cushing's Disease - common signs and symptoms, tips for living with Cushing's, upcoming clinical trials and developing treatment options.